GPT Healthcare Limited has scheduled a meeting of the Board of Directors for Monday, August 3, 2026. The primary agenda of the meeting is to consider and approve the Unaudited Financial Results along with the Limited Review Report of the Statutory Auditor for the first quarter ended June 30, 2026.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regarding insider trading compliance, the company confirms that the trading window for trading in the company's securities will continue to remain closed until August 5, 2026. This closure period extends until 48 hours after the unpublished price sensitive information (the quarterly results) are submitted to the Stock Exchanges, in accordance with the company's "Code of Conduct for Prevention of Insider Trading". This continues the trading window closure that was previously communicated via letter dated June 27, 2026.
The notice of this board meeting is also available on the company's website at https://ilshospitals.com/